A prospective assessment of an ‘a la carte’ regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers
C. D'Arondel, M. Munteanu, J. Moussalli, V. Thibault, S. Naveau, A. Simon, D. Messous, R. Morra, C. Blot, T. PoynardVolume:
13
Year:
2006
Language:
english
Pages:
8
DOI:
10.1111/j.1365-2893.2005.00668.x
File:
PDF, 93 KB
english, 2006